Skip to main content

EFECTO DE UNA DIETA MEDITERRANEA RICA EN ACEITE DE OLIVA VIRGEN SOBRE LA REGRESION DE DIABETES MELLITUS TIPO 2 DE RECIENTE DIAGNOSTICO: ESTUDIO CORDIOPREV-DIRECT

AGL2015-67896-P

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2015
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DE CÓRDOBA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Helvia. Repositorio Institucional de la Universidad de Córdoba
Publication Artículo científico (JournalArticle)

Lipoprotein particle profile in the presence of peripheral artery disease among patients with coronary heart disease: Data from the CORDIOPREV study

  • Cruz Ares, Silvia de la
  • Coronado Carvajal, P.
  • Rangel Zúñiga, Oriol Alberto
  • Torres‑Peña, J.D.
  • Arenas de Larriva, Antonio P.
  • López-Moreno, Alejandro
  • Katsiki, Niki
  • Ordovás, José M.
  • Delgado-Lista, Javier
  • Pérez-Martínez, Pablo
  • Gutiérrez-Mariscal, Francisco M.
  • López-Miranda, José
BACKGROUND: Dyslipidemia is recognized as a contributing factor to peripheral artery disease (PAD). However, the influence of lipoprotein subfractions as compared to traditional serum lipid lev- els is not well-understood. Objective: This study explores the association between lipoprotein subfractions and the occurrence of PAD in patients with coronary heart disease (CHD). METHODS: In the CORDIOPREV study, 981 patients were categorized based on PAD diagnosis, determined by an ankle-brachial index (ABI) ≤0.9. Those with ABI >0.9 and <1.4 were consid- ered PAD-free, while patients with ABI ≥1.4 were excluded. We employed high-throughput nuclear magnetic resonance (NMR) spectroscopy to analyze the concentration and lipid content of lipoprotein subfractions. RESULTS: PAD patients exhibited significantly lower levels of medium high-density lipoprotein (HDL) particles and reduced concentrations of associated lipids within these subfractions except for triglycerides. A higher concentration of large or medium HDL particles correlated with a lower PAD prevalence (odds ratio [OR]: 0.61, 95% CI, 0.44-0.84; OR: 0.59, 95% CI, 0.43-0.81, respectively). In multivariate logistic regression, medium HDL particle levels inversely associated with PAD presence (OR: 0.69, 95% CI, 0.48–0.99, P = .044) after adjustment for confounding factors. CONCLUSIONS: The presence of PAD among CHD patients inversely correlates with medium HDL particle concentrations as determined by NMR. These insights could advance our understanding of PAD pathophysiology and HDL metabolism.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publication Artículo científico (JournalArticle)

Apolipoprotein E genetic variants interact with Mediterranean diet to modulate postprandial hypertriglyceridemia in coronary heart disease patients: CORDIOPREV study

  • Gómez Delgado, Francisco
  • Alcalá Díaz, Juan Francisco
  • León-Acuña, Ana
  • López-Moreno, Javier
  • Delgado-Lista, Javier
  • Gómez Marín, Beatriz
  • Roncero-Ramos, Irene
  • Yubero-Serrano, Elena M.
  • Rangel-Zuñiga, Oriol Alberto
  • Vals-Delgado, Cristina
  • Luque, Raúl M.
  • Ordovás, José María
  • López-Miranda, José
  • Pérez-Martínez, Pablo
Background: We try to explore whether long-term consumption of two healthy dietary patterns (low-fat [LF] diet or Mediterranean diet [MedDiet]) interacts with the apolipoprotein E (APOE) single-nucleotide polymorphisms (SNPs: rs439401, rs440446 and rs7412) modulating postprandial hypertriglyceridemia (ppHTG) in coronary heart disease (CHD) patients. Methods and results: We selected patients from the CORDIOPREV study with genotyping and who underwent an oral fat load test (FLT) at baseline and after 3 years follow-up (n = 506). After 3 years of follow-up, we found a gene-diet interaction between the APOE rs439401 SNP and MedDiet. Specifically, T-allele carriers in the MedDiet group showed a more significant decrease in postprandial triglycerides (TG: P = 0.03) and large triacylglycerol-rich lipoproteins (TRLs) TG (large TRLs TG; P = 0.01) compared with CC subjects. Consistently, the area under the curve of TG (AUC-TG; P-interaction = 0.03) and AUC-large TRLs TG (P-interaction = 0.02) were significantly lower in T-allele carriers compared with CC subjects. Conclusions: The long-term consumption of a MedDiet modulates ppHTG through APOE genetic variants in CHD patients. This gene-diet interaction may contribute to a more precise dietary advice in CHD patients.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publication Artículo científico (JournalArticle)

Long-term dietary adherence and changes in dietary intake in coronary patients after intervention with a Mediterranean diet or a low-fat diet: the CORDIOPREV randomized trial

  • Quintana-Navarro, Gracia M.
  • Alcalá Díaz, Juan Francisco
  • López-Moreno, Javier
  • Pérez‑Corral, Isabel
  • León-Acuña, Ana
  • Torres‑Peña, J.D.
  • Rangel Zúñiga, Oriol Alberto
  • Arenas de Larriva, Antonio P.
  • Corina Baba, Andreea
  • Camargo García, A.
  • Yubero-Serrano, Elena M.
  • Rodríguez-Cantalejo, Fernando
  • García-Ríos, Antonio
  • Luque, R.M.
  • Ordovás, José María
  • Pérez-Martínez, Pablo
  • López-Miranda, José
  • Delgado-Lista, Javier
Purpose: Adherence to a healthy dietary pattern positively influences clinical outcomes in cardiovascular prevention, but long-term adherence is difficult to maintain. We evaluated 5-year changes in dietary habits, adherence achieved, and its maintenance in a cohort of coronary patients from the CORDIOPREV study. Methods: 1002 coronary patients were randomized to a Mediterranean diet (n = 502) or a low-fat diet (n = 500) and received individual-group-telephone visits and personalized dietary advice. A validated food-frequency questionnaire, a 14-point Mediterranean diet adherence screener, and a 9-point low-fat diet adherence score were used. Dietary adherence was categorized into Low, Medium, and High Adherence. Changes in nutrient intake, food consumption, and adherence were analyzed on a yearly basis. The maintenance of long-term dietary adherence was evaluated using data after the first year and fifth year. Results: From baseline to 5 years, significant increases were observed in overall dietary adherence (Mediterranean diet from 8.9 to 11.4; low-fat diet from 3.9 to 7.1) and in the percentage of patients considered High Adherence (Mediterranean diet from 41 to 89%; low-fat diet from 4 to 67%). When we evaluated the maintenance of adherence, patients considered Low and Medium Adherence at 1 year increased their adherence at the 5 years with both diets and patients considered High Adherence maintained their adherence with a Mediterranean diet, but decreased their adherence with a low-fat diet. Conclusions: A comprehensive dietary intervention results in an overall long-term improvement and maintenance of adherence to the Mediterranean and low-fat diets. In our population, the Mediterranean diet group achieved a high level of adherence in the short term which was maintained in the long term.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publication Artículo científico (JournalArticle)

Risk of short telomere as biomarker of diabetes mellitus type 2 status in the CORDIOPREV study, Riesgo de telómero corto como biomarcador de diabetes mellitus tipo 2 en el estudio CORDIOPREV

  • Ojeda-Rodríguez, Ana
  • Párraga-Viudez, María José
  • Romero-Cabrera, Juan Luis
  • López-Moreno, Alejandro
  • Arenas-Montes, Javier
  • Pérez-Caballero, Ana I.
  • Luque, Raúl M.
  • Delgado-Lista, Javier
  • Rangel-Zuñiga, Oriol Alberto
  • López-Miranda, José
Embargado hasta 19/12/2026, Background The presence of type 2 diabetes mellitus (T2DM) in cardiovascular disease (CVD) is associated with poorer clinical outcomes. To identify biomarkers is essential to predict T2DM onset and progression in the context of secondary prevention. Telomere length (TL), a marker of cellular aging, has been linked to oxidative stress, inflammation, and metabolic dysfunction, including diabetes-related complications. This study aims to evaluate TL as a potential biomarker for T2DM in patients with coronary heart disease (CHD). Methods We included 956 patients from the CORDIOPREV study with available TL data. Participants were classified according to their diabetes status at the end of the dietary intervention: 407 were free of T2DM and 549 were classified as having T2DM. TL was measured by quantitative PCR. Patients with TL values below the 20th percentile of the study population were categorized as having short telomeres. Results TL was significantly shorter in T2DM patients compared to non-T2DM (1.26 ± 0.74 vs. 1.38 ± 0.84; p = 0.026). Each 1-SD increase in TL was associated with a 17% lower risk of T2DM (OR 0.83, 95% CI 0.69–0.98). Patients at risk of short TL (<20th percentile) showed a higher prevalence of T2DM (20% vs. 17%; p = 0.035) and a 42% increased risk of its presence (OR 1.42, 95% CI 0.99–2.02). In stepwise regression models, TL, age, BMI, insulin, triglycerides, and HbA1c emerged as independent predictors of T2DM. After adjusting for fasting glucose, TL lost significance as a continuous variable, but short TL risk remained independently associated with T2DM (OR 1.57, p = 0.049). Conclusions Shorter TL is associated with the presence of T2DM in patients with CHD, supporting its potential role as an independent biomarker for T2DM risk in secondary prevention., Resumen Antecedentes La presencia de diabetes mellitus tipo 2 (DMT2) en la enfermedad cardiovascular se asocia con peores resultados clínicos. Identificar biomarcadores es esencial para predecir la aparición y progresión de la DMT2 en el contexto de la prevención secundaria. La longitud de los telómeros (LT), un marcador de envejecimiento celular se ha relacionado con el estrés oxidativo, la inflamación y la disfunción metabólica, incluidas las complicaciones asociadas a la diabetes. Este estudio tiene como objetivo evaluar la LT como un biomarcador potencial de la DMT2 en pacientes con enfermedad coronaria (EC). Métodos Se incluyeron 956 pacientes del estudio CORDIOPREV con datos disponibles de LT. Los participantes fueron clasificados según su estado diabético al final de la intervención dietética: 407 estaban libres de DMT2 y 549 fueron clasificados con DMT2. La LT se midió mediante PCR cuantitativa. Los pacientes con valores de LT por debajo del percentil 20 de la población del estudio fueron categorizados como en riesgo de telómeros cortos. Resultados La LT fue significativamente más corta en los pacientes con DMT2 en comparación con los no diabéticos (1,26 ± 0,74 vs. 1,38 ± 0,84; p = 0,026). Cada incremento de 1 DE en LT se asoció con un 17% menos de riesgo de DMT2 (OR 0,83; IC 95%: 0,69–0,98). Los pacientes en riesgo de LT corta (< percentil 20) mostraron una mayor prevalencia de DMT2 (20% vs. 17%; p = 0,035) y un aumento del 42% en el riesgo de su presencia (OR 1,42; IC 95%: 0,99–2,02). En los modelos de regresión por pasos, la LT, la edad, el IMC, la insulina, los triglicéridos y la HbA1c emergieron como predictores independientes de la DMT2. Tras ajustar por glucosa en ayunas, la LT perdió significancia como variable continua, pero el riesgo de LT corta permaneció asociado de manera independiente con la DMT2 (OR 1,57; p = 0,049). Conclusiones Una LT más corta se asocia con la presencia de DMT2 en pacientes con EC, lo que respalda su potencial papel como biomarcador independiente de riesgo de DMT2 en prevención secundaria.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Consumption of Two Healthy Dietary Patterns Restored Microbiota Dysbiosis in Obese Patients with Metabolic Dysfunction

  • Haro, Carmen
  • García-Carpintero, Sonia
  • Rangel-Zúñiga, Ariol A.
  • Alcalá-Díaz, Juan F.
  • Landa, Blanca B.
  • Clemente, José C.
  • Pérez-Martínez, Pablo
  • López-Miranda, José
  • Pérez-Jiménez, Francisco
  • Camargo, Antonio
[Scope] The consumption of two healthy diets (Mediterranean (MED) and low‐fat (LF) diets) may restore the gut microbiome dysbiosis in obese patients depending on the degree of metabolic dysfunction., [Methods and results] The differences in bacterial community at baseline and after 2 years of dietary intervention of 106 subjects from the CORDIOPREV study were analyzed, 33 of whom were obese patients with severe metabolic disease (5 criteria for metabolic syndrome) (MetS‐OB), 32 obese patients without metabolic dysfunction (2 or less criteria for metabolic syndrome) (NonMetS‐OB) and 41 non‐obese subjects (NonMetS‐NonOB). Our study showed a marked dysbiosis in people with severe metabolic disease (Met‐OB), compared with obese people without MetS (NonMetS‐OB) and non‐obese people (NonMetS‐NonOB). This disbiotic pattern was reversed by consumption of both MED (35% of calories as fat (22% MUFA fat, 6% PUFA fat and <10% saturated fat) or LF (<30% total fat (<10% saturated fat, 12%–14% MUFA fat and 6–8% PUFA fat) diets, whereas no significant microbiota changes were observed in NonMetS‐NonOB and NonMetS‐OB groups., [Conclusion] Our results suggest that the chronic intake of two healthy dietary patterns partially restores the gut microbiome dysbiosis in obese patients with coronary heart disease, depending on the degree of metabolic dysfunction., The CORDIOPREV study is supported by the Fundación Patrimonio Comunal Olivarero, Junta de Andalucía (Consejería de Salud, Consejería de Agricultura y Pesca, Consejería de Innovación, Ciencia y Empresa), Diputaciones de Jaén y Córdoba, Centro de Excelencia en Investigación sobre Aceite de Oliva y Salud and Ministerio de Medio Ambiente, Medio Rural y Marino, Gobierno de España. The CIBEROBN is an initiative of the Instituto de Salud Carlos III, Madrid, Spain. It was also partly supported by research grants from Ministerio de Economía y Competitividad (AGL2012/39615, PIE14/00005, and PIE 14/00031 to J.L.‐M.; AGL2015/‐67896‐P to J.L.‐M. and A.C.; CP14/00114 to A.C.; FIS PI13/00023 to J.D.‐L.; FIS PI13/00185 to P. P.‐M.; PI13/00619 to F. P.‐J.; FIS PI16/01777 to P. P.‐M. and F. P.‐J.); Consejería de Innovación, Ciencia y Empresa, Proyectos de Investigación de Excelencia, Junta de Andalucía (CVI‐7450 to J. L.‐M.); Fondo Europeo de Desarrollo Regional (FEDER). A. C. is supported by an ISCIII research contract, Instituto de Salud Carlos III (Programa Miguel‐Servet CP14/00114)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Interplay between gonadal hormones and postnatal overfeeding in defining sex-dependent differences in gut microbiota architecture

  • Santos‐Marcos, José A.
  • Barroso, Alexia
  • Rangel-Zúñiga, Ariol A.
  • Perdices-López, Cecilia
  • Haro, Carmen
  • Sánchez-Garrido, Miguel Ángel
  • Molina‐Abril, Helena
  • Ohlsson, Claes
  • Pérez-Martínez, Pablo
  • Poutanen, Matti
  • López-Miranda, José
  • Pérez-Jiménez, Francisco
  • Tena-Sempere, Manuel
  • Camargo, Antonio
Aging is associated with a decline in sex hormones, variable between sexes, that has an impact on many different body systems and might contribute to age-related disease progression. We aimed to characterize the sex differences in gut microbiota, and to explore the impact of depletion of gonadal hormones, alone or combined with postnatal overfeeding, in rats. Many of the differences in the gut microbiota between sexes persisted after gonadectomy, but removal of gonadal hormones shaped several gut microbiota features towards a more deleterious profile, the effect being greater in females than in males, mainly when animals were concurrently overfed. Moreover, we identified several intestinal miRNAs as potential mediators of the impact of changes in gut microbiota on host organism physiology. Our study points out that gonadal hormones contribute to defining sex-dependent differences of gut microbiota, and discloses a potential role of gonadal hormones in shaping gut microbiota, as consequence of the interaction between sex and nutrition. Our data suggest that the changes in gut microbiota, observed in conditions of sex hormone decline, as those caused by ageing in men and menopause in women, might exert different effects on the host organism, which are putatively mediated by gut microbiota-intestinal miRNA cross-talk., This work was supported by research grants from Ministerio de Economia y Competitividad (CP14/00114 to A.C.; PIE14/00005 to JLM and MTS; AGL2015/- 67896-P to JL-M and AC); Ministerio de Ciencia e Innovacion (FIS PI19/00299 to AC; DTS19/00007 to AC; PI16/01777 to PPM); Fondo Europeo de Desarrollo Regional (FEDER). A.C. is supported by an ISCIII research contract, Instituto de Salud Carlos III (Programa Miguel-Servet CP14/00114 and CPII19/ 00007).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A Diet-Dependent Microbiota Profile Associated with Incident Type 2 Diabetes: From the CORDIOPREV Study

  • Camargo, Antonio
  • Vals-Delgado, Cristina
  • Alcalá-Díaz, Juan F.
  • Villasanta-Gonzalez, Alejandro
  • Gómez-Delgado, Francisco
  • Haro, Carmen
  • León-Acuña, Ana
  • Cardelo, Magdalena P.
  • Torres-Peña, José D.
  • Guler, Ipek
  • Malagon, María M.
  • Ordovás, José M.
  • Pérez-Martínez, Pablo
  • Delgado-Lista, Javier
  • López-Miranda, José
Scope The differences between the baseline gut microbiota of patients who developed type 2 diabetes (T2D) consuming a low‐fat (LF) or a Mediterranean (Med) diet are explored and risk scores are developed to predict the individual risk of developing T2D associated with the consumption of LF or Med diet. Methods and Results All the patients from the CORDIOPREV study without T2D at baseline (n = 462) whose fecal sample are available, are included. Gut microbiota is analyzed by 16S sequencing and the risk of T2D after a median follow‐up of 60 months assessed by Cox analysis. Linear discriminant analysis effect size (LEfSe) analysis shows a different baseline gut microbiota in patients who developed T2D consuming LF and Med diets. A higher abundance of Paraprevotella, and lower Gammaproteobacteria and B. uniformis are associated with T2D risk when an LF diet is consumed. In contrast, higher abundances of Saccharibacteria, Betaproteobacteria, and Prevotella are associated with T2D risk when a Med diet is consumed. Conclusion The results suggest that different interactions between the microbiome and dietary patterns may partially determine the risk of T2D development, which may be used for selecting personalized dietary models to prevent T2D., Agencia de Innovación y Desarrollo de Andalucía. Grant Number: CVI‐7450 Instituto de Salud Carlos III. Grant Numbers: CP14/00114, CPII19/00007, DTS19/00007, FIS PI13/00023, PI16/01777, PI19/00299, PIE 14/00031, PIE14/00005 European Regional Development Fund. Grant Number: na Secretaría de Estado de Investigación, Desarrollo e Innovación. Grant Number: AGL2015‐67896‐P
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trial

  • Gutiérrez-Mariscal, Francisco Miguel
  • López-Moreno, Alejandro
  • Torres-Peña, José D.
  • Gómez-Luna, Purificación
  • Arenas-de Larriva, Antonio P.
  • Romero-Cabrera, Juan Luis
  • Luque, Raúl M.
  • Uribarri, Jaime
  • Pérez-Martínez, Pablo
  • Delgado-Lista, Javier
  • Yubero-Serrano, Elena María
  • López-Miranda, José
16 Páginas.-- 5 Figuras.-- 2 Tablas, Background: Increasing evidence supports the role of advanced glycation end products (AGEs) in atherosclerosis in both diabetic and non-diabetic patients, suggesting that therapeutic strategies targeting AGEs may offer potential benefits in this population. The Mediterranean diet is associated with improved biomarkers and anthropometric measurements related with atherosclerosis in addition to its ability to modulate AGE metabolism. Our aim was to determine whether the reduction in atherosclerosis progression (measured by changes in intima-media thickness of both common carotid arteries (IMT-CC)), observed after consumption of a Mediterranean diet compared to a low-fat diet, is associated with a modulation of circulating AGE levels in patients with coronary heart disease (CHD). Methods: 1002 CHD patients were divided in: (1) Non-increased IMT-CC patients, whose IMT-CC was reduced or not changed after dietary intervention and (2) Increased IMT-CC patients, whose IMT-CC was increased after dietary intervention. Serum AGE levels (methylglyoxal–MG and Nε-Carboxymethyllysine-CML) and parameters related to AGE metabolism (AGER1 and GloxI mRNA and sRAGE levels) and reduced glutathione (GSH) levels were measured before and after 5-years of dietary intervention. Results: The Mediterranean diet did not affect MG levels, whereas the low-fat diet significantly increased them compared to baseline (p = 0.029), leading to lower MG levels following the Mediterranean diet than the low-fat diet (p < 0.001). The Mediterranean diet, but not the low-fat diet, produced an upregulation of AGE metabolism, with increased AGER1 and GloxI gene expression as well as increased GSH and sRAGE levels in Non-increased IMT-CC patients (all p < 0.05). Although the Mediterranean diet increased MG levels in Increased IMT-CC patients, this increment was lower compared to the low-fat diet (all p < 0.05). Conclusions: Our results suggest that an improvement in modulation of AGE metabolism, which facilitates better management of circulating AGE levels, may be one of the mechanisms through which the Mediterranean diet, compared to a low-fat diet, reduces the progression of atherosclerosis in patients with CHD. Trial registration https://clinicaltrials.gov/ct2/show/NCT00924937, Clinicaltrials.gov number, NCT00924937. Graphical abstract: (Figure presented.)., The CORDIOPREV study was supported by the Fundación Patrimonio Comunal Olivarero(Cordioprev-CEAS, 1/2016 to Jose Lopez-Miranda). This study also received research grants from Ministerio de Ciencia e Innovación (AGL2012-39615, AGL2015-67896-P and PID2019-104362RB-I00funded by MCIN/AEI/1.0.13039/501100011033 to Jose Lopez-Miranda), from Consejería de Salud-Junta de Andalucía (PC-0283-2017 to Elena M. Yubero-Serrano) and FIS (PI18/01822 and PI21/00383 toElena M Yubero-Serrano), funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union. Elena M Yubero-Serrano was the recipient of the Nicolas Monardes Programme from the“Servicio Andaluz de Salud, Junta de Andalucia”, Spain (C1-0005-2019). Francisco M Gutierrez-Mariscal is supported by a CIBEROBN postdoctoral research contract. The funding bodies had no role in thestudy design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Gut Microbiota Interacts with Dietary Habits in Screenings for Early Detection of Colorectal Cancer

  • Vega-Rojas, Ana
  • Haro, Carmen
  • Molina-Abril, Helena
  • Guil-Luna, Silvia
  • Santos‐Marcos, José A.
  • Gutierrez-Mariscal, Francisco Miguel
  • Garcia-Fernandez, Helena
  • Caballero-Villarraso, Javier
  • Rodriguez-Ariza, Antonio
  • López-Miranda, José
  • Pérez-Martínez, Pablo
  • Hervas, Antonio
  • Camargo, Antonio
[Background/Objectives] Gut microbiota interacts with nutrients, which may be relevant to assigning a microbial signature to colorectal cancer (CRC). We aim to evaluate the potential of gut microbiota combined with dietary habits in the early detection of pathological findings related to CRC in the course of a screening program., [Methodology] The colonoscopy performed on 152 subjects positive for fecal occult blood test showed that 6 subjects had adenocarcinoma, 123 had polyps, and 23 subjects had no pathological findings. Gut microbiota was analyzed by 16S metagenomic. Caret package was used to build the classification models in R., [Results] Random forest (RF) classifier models were used to test the potential of gut microbiota alone or combined with dietary habits as a biomarker to discern between individuals with CRC-related lesions (polyps or adenocarcinoma) versus individuals without pathological findings. RF classifier models yielded an area under the curve of 0.790 using gut microbiota data, 0.710 using dietary habits data, and 0.804 in the combined model including gut microbiota and dietary habits data. The abundance of Suterella, Oscillospirales, Proteobacteria, and Burkholderiales was highly discriminant between groups, together with the consumption of fruit and vegetables and the consumption of carbonated and/or sweetened beverages., [Conclusions] Our results suggest that the interaction between gut microbiota and dietary habits is relevant when a microbial signature is used as a marker in CRC. Moreover, gut microbiota signature and information about the dietary habits of the individuals seem to be important for improving screening programs for the early detection of CRC., This research was funded by the Consejeria de Salud, Junta de Andalucía (PIN-0156-2016 to C.H.); by the Consejeria de Salud y Familias, Junta de Andalucía (PI-0055-2021 to A.C.); by the Ministerio de Ciencia e Innovacion, Spain, through the grants AGL2015-67896-P to J.L.-M. and A.C.; grant PID2019-104362RB funded by MCIN/AEI/10.13039/501100011033; by the ISCIII, Spain, grants CP14/00114, PI19/00299, DTS19/00007, and PI22/00925 to A.C.; and co-funded by the European Union. Antonio Camargo is supported by an ISCIII research contract (Programa Miguel-Servet CP14/00114 and CPII19/00007) and by Servicio Andaluz de Salud-Junta de Andalucia (Nicolas Monardes Programme Contract C1-0001-2022) funding., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Differences in splicing factors may predict type 2 diabetes remission in the CORDIOPREV study

  • Ojeda-Rodríguez, Ana
  • Torres-Peña, José D.
  • Arenas de Larriva, Antonio Pablo
  • Rangel-Zúñiga, Oriol Alberto
  • Podadera-Herreros, Alicia
  • Boughanem, Hatim
  • García, Miguel E. G.
  • López-Moreno, Alejandro
  • Katsiki, Niki
  • Luque, Raúl M.
  • Pérez-Martínez, Pablo
  • Delgado-Lista, Javier
  • Yubero-Serrano, Elena María
  • López-Miranda, José
12 Páginas.-- 4 Figuras, Alternative splicing is a post-transcriptional process resulting in multiple protein isoforms from a single gene. Abnormal splicing may lead to metabolic diseases, including type 2 diabetes mellitus (T2DM). To identify the splicing factor expression that predicts T2DM remission in coronary heart disease (CHD) patients, we identified newly diagnosed T2DM at baseline (n = 190) from the CORDIOPREV study. Patients were classified as Responders (T2DM remission during 5 years without antidiabetic drugs) or non-Responders. Baseline dysregulation in 5 splicing factors (MBNL1, RBM5, hnRNP G/RBMX, CD44, NT5E) distinguished Responders from non-Responders. Adding these factors to clinical variables [AUC = 0.67], insulin resistance, and beta-cell indexes [AUC = 0.76], improved T2DM remission prediction [AUC = 0.80]. Cox regression analysis showed those with higher remission scores had a 2.63-fold increased remission probability. To conclude, a set of splicing factors that contribute to predicting T2DM remission in patients with CHD has been identified. Further research is needed to elucidate these findings' clinical relevance., The CORDIOPREV study is supported by the Fundación Patrimonio Comunal Olivarero (Cordioprev-CEAS, 1/2016 to J.L.-M.). The main sponsor was not involved in the design or carrying out the study, and its participation was limited to funding and providing the olive oil used in the study. This study also received research grants from Ministerio de Ciencia e Innovación (AGL2012-39615, AGL2015-67896-P and PID2019-104362RB-I00 funded by MCIN/AEI/1.0.13039/501100011033 to J.L.-M.), from Consejería de Salud-Junta de Andalucía (PC-0283-2017 to E.M.Y.-S.) and FIS (PI18/01822 and PI21/00383 to E.M.Y.-S.), integrated into the framework of the National Plan for Scientific Research, Technological Development and Innovation 2013–2016, co-financed by the Instituto de Salud Carlos III (ISCIII) of Spain and also by the Directorate General for Assessment and Promotion of Research and the EU’s European Regional Development Fund (FEDER). A.O.-R. and H.B. were the recipients of Sara Borrell grants (CD21/00099 and CD22/00053, respectively) from the ISCIII. The funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank the EASP (Escuela Andaluza de Salud Publica), Granada (Spain), for carrying out the randomization process in this study. The CIBEROBN is an initiative of the Instituto de Salud Carlos III, Madrid, Spain. The authors declare no competing interests. The authors read and approved the final manuscript., Peer reviewed